| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 9 | |
| #2 | Australia | 7 | |
| #3 | China | 7 | |
| #4 | Republic of Korea | 7 | |
| #5 | United States | 7 | |
| #6 | Japan | 5 | |
| #7 | WIPO (World Intellectual Property Organization) | 5 | |
| #8 | Canada | 4 | |
| #9 | Israel | 4 | |
| #10 | Brazil | 3 | |
| #11 | Mexico | 3 | |
| #12 | Hong Kong | 2 | |
| #13 | Singapore | 2 | |
| #14 | South Africa | 2 | |
| #15 | United Kingdom | 1 | |
| #16 | India | 1 | |
| #17 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Foods and drinks | |
| #5 | Measurement | |
| #6 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Measuring microorganism processes | |
| #5 | Enzymes | |
| #6 | Analysing materials | |
| #7 | Unspecified technologies | |
| #8 | Unspecified technologies | |
| #9 | Peptides | |
| #10 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kaufmann Joerg | 37 |
| #2 | Keil Oliver | 35 |
| #3 | Santel Ansgar | 30 |
| #4 | Kaufmann Jorg | 17 |
| #5 | Klippel-Giese Anke | 10 |
| #6 | Giese Klaus | 8 |
| #7 | Schwarzer Rolf | 6 |
| #8 | Anke Klippel-Giese | 5 |
| #9 | Kaufmann Jörg | 5 |
| #10 | Joerg Kaufmann | 3 |
| Publication | Filing date | Title |
|---|---|---|
| GB201707206D0 | RXi with gainac targeting ligand | |
| AU2013231060A1 | Use of protein kinase n beta | |
| EP2398903A1 | Means for inhibiting the expression of ang2 | |
| WO2010034487A2 | Means for inhibiting the expression of orc-1 | |
| EP2546337A1 | Means for inhibiting the expression of protein kinase 3 | |
| KR20140088227A | Means for inhibiting the expression of protein kinase 3 | |
| US2009252783A1 | Means for inhibiting the expression of cd31 | |
| BRPI0519468A2 | coated lipid complexes and their use | |
| CN1968714A | Lipids, lipid complexes and use thereof | |
| EP2072619A1 | Factor involved in metastasis and uses thereof | |
| EP1389637A1 | Blunt-ended interfering RNA molecules |